Literature DB >> 15650173

Virus particle core defects caused by mutations in the human immunodeficiency virus capsid N-terminal domain.

Isabel Scholz1, Brian Arvidson, Doug Huseby, Eric Barklis.   

Abstract

The N-terminal domains (NTDs) of the human immunodeficiency virus type 1 (HIV-1) capsid (CA) protein have been modeled to form hexamer rings in the mature cores of virions. In vitro, hexamer ring units organize into either tubes or spheres, in a pH-dependent fashion. To probe factors which might govern hexamer assembly preferences in vivo, we examined the effects of mutations at CA histidine residue 84 (H84), modeled at the outer edges of NTD hexamers, as well as a nearby histidine (H87) in the cyclophilin A (CypA) binding loop. Although mutations at H87 yielded infectious virions, mutations at H84 produced assembly-competent but poorly infectious virions. The H84 mutant viruses incorporated wild-type levels of CypA and viral RNAs and showed nearly normal signals in virus entry assays. However, mutant CA proteins assembled aberrant virus cores, and mutant core fractions retained abnormally high levels of CA but reduced reverse transcriptase activities. Our results suggest that HIV-1 CA residue 84 contributes to a structure which helps control either NTD hexamer assembly or the organization of hexamers into higher-order structures.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15650173      PMCID: PMC544128          DOI: 10.1128/JVI.79.3.1470-1479.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  HIV-1 capsid protein forms spherical (immature-like) and tubular (mature-like) particles in vitro: structure switching by pH-induced conformational changes.

Authors:  L S Ehrlich; T Liu; S Scarlata; B Chu; C A Carter
Journal:  Biophys J       Date:  2001-07       Impact factor: 4.033

2.  Image reconstructions of helical assemblies of the HIV-1 CA protein.

Authors:  S Li; C P Hill; W I Sundquist; J T Finch
Journal:  Nature       Date:  2000-09-21       Impact factor: 49.962

3.  Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A.

Authors:  C Aiken
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter.

Authors:  G Zlokarnik; P A Negulescu; T E Knapp; L Mere; N Burres; L Feng; M Whitney; K Roemer; R Y Tsien
Journal:  Science       Date:  1998-01-02       Impact factor: 47.728

5.  Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid.

Authors:  T R Gamble; F F Vajdos; S Yoo; D K Worthylake; M Houseweart; W I Sundquist; C P Hill
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

6.  Organization of HIV-1 capsid proteins on a lipid monolayer.

Authors:  E Barklis; J McDermott; S Wilkens; S Fuller; D Thompson
Journal:  J Biol Chem       Date:  1998-03-27       Impact factor: 5.157

7.  Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly.

Authors:  U K von Schwedler; T L Stemmler; V Y Klishko; S Li; K H Albertine; D R Davis; W I Sundquist
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

8.  Cells with high cyclophilin A content support replication of human immunodeficiency virus type 1 Gag mutants with decreased ability to incorporate cyclophilin A.

Authors:  B Ackerson; O Rey; J Canon; P Krogstad
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

9.  Further evidence for hexagonal organization of HIV gag protein in prebudding assemblies and immature virus-like particles.

Authors:  M V Nermut; D J Hockley; P Bron; D Thomas; W H Zhang; I M Jones
Journal:  J Struct Biol       Date:  1998-10       Impact factor: 2.867

10.  Assembly and analysis of conical models for the HIV-1 core.

Authors:  B K Ganser; S Li; V Y Klishko; J T Finch; W I Sundquist
Journal:  Science       Date:  1999-01-01       Impact factor: 47.728

View more
  35 in total

1.  A new functional role of HIV-1 integrase during uncoating of the viral core.

Authors:  Marisa S Briones; Samson A Chow
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

2.  The matrix protein of human immunodeficiency virus is cleaved and packed into virion cores.

Authors:  A G Bukrinskaya; G K Vorkunova; M E Burshtein; M Stevenson
Journal:  Dokl Biol Sci       Date:  2006 May-Jun

3.  Analysis of human immunodeficiency virus matrix domain replacements.

Authors:  Isabel Scholz; Amelia Still; Tenzin Choesang Dhenub; Kelsey Coday; Mike Webb; Eric Barklis
Journal:  Virology       Date:  2007-11-08       Impact factor: 3.616

Review 4.  Novel approaches to inhibiting HIV-1 replication.

Authors:  Catherine S Adamson; Eric O Freed
Journal:  Antiviral Res       Date:  2009-09-24       Impact factor: 5.970

5.  Contributions of Charged Residues in Structurally Dynamic Capsid Surface Loops to Rous Sarcoma Virus Assembly.

Authors:  Katrina J Heyrana; Boon Chong Goh; Juan R Perilla; Tam-Linh N Nguyen; Matthew R England; Maria C Bewley; Klaus Schulten; Rebecca C Craven
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

6.  Analysis of HIV-1 Gag protein interactions via biotin ligase tagging.

Authors:  Christopher Ritchie; Isabel Cylinder; Emily J Platt; Eric Barklis
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

Review 7.  HIV-1 uncoating: connection to nuclear entry and regulation by host proteins.

Authors:  Zandrea Ambrose; Christopher Aiken
Journal:  Virology       Date:  2014-02-20       Impact factor: 3.616

8.  Second site reversion of a mutation near the amino terminus of the HIV-1 capsid protein.

Authors:  Claudia S López; Seyram M Tsagli; Rachel Sloan; Jacob Eccles; Eric Barklis
Journal:  Virology       Date:  2013-09-21       Impact factor: 3.616

9.  Characterization of the in vitro HIV-1 capsid assembly pathway.

Authors:  Eric Barklis; Ayna Alfadhli; Carolyn McQuaw; Suraj Yalamuri; Amelia Still; Robin Lid Barklis; Ben Kukull; Claudia S López
Journal:  J Mol Biol       Date:  2009-02-03       Impact factor: 5.469

10.  Sultam thiourea inhibition of West Nile virus.

Authors:  Eric Barklis; Amelia Still; Mohammad I Sabri; Alec J Hirsch; Janko Nikolich-Zugich; James Brien; Tenzin Choesang Dhenub; Isabel Scholz; Ayna Alfadhli
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.